306 related articles for article (PubMed ID: 17617181)
1. Invasive fungal infections and antifungal therapies in solid organ transplant recipients.
Gabardi S; Kubiak DW; Chandraker AK; Tullius SG
Transpl Int; 2007 Dec; 20(12):993-1015. PubMed ID: 17617181
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic antifungal agents used after lung transplantation.
Marino E; Gallagher JC
Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
5. Invasive Candida infections in solid organ transplant recipient children.
Sensoy G; Belet N
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):317-24. PubMed ID: 21417871
[TBL] [Abstract][Full Text] [Related]
6. Antifungal prophylaxis in solid organ transplant recipients.
Brizendine KD; Vishin S; Baddley JW
Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
[TBL] [Abstract][Full Text] [Related]
8. Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.
Grossi PA; Gasperina DD; Barchiesi F; Biancofiore G; Carafiello G; De Gasperi A; Sganga G; Menichetti F; Montagna MT; Pea F; Venditti M; Viale P; Viscoli C; Nanni Costa A
Transplant Proc; 2011; 43(6):2463-71. PubMed ID: 21839295
[TBL] [Abstract][Full Text] [Related]
9. Fungal infections in solid organ transplant recipients.
Hadley S; Karchmer AW
Infect Dis Clin North Am; 1995 Dec; 9(4):1045-74. PubMed ID: 8747778
[TBL] [Abstract][Full Text] [Related]
10. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
11. Invasive fungal infections in liver transplantation.
Liu X; Ling Z; Li L; Ruan B
Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
[TBL] [Abstract][Full Text] [Related]
12. [Fungal infections in transplantation patients].
Colomba C; Antinori S
Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
[TBL] [Abstract][Full Text] [Related]
13. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
Muñoz P; Singh N; Bouza E
Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
[TBL] [Abstract][Full Text] [Related]
14. Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
[TBL] [Abstract][Full Text] [Related]
15. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis.
Nucci M; Anaissie E
Clin Chest Med; 2009 Jun; 30(2):295-306, vii. PubMed ID: 19375636
[TBL] [Abstract][Full Text] [Related]
16. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
17. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit.
Pugliese F; Ruberto F; Cappannoli A; Perrella SM; Bruno K; Martelli S; Marcellino V; D'Alio A; Diso D; Rossi M; Corradini SG; Morabito V; Rolla M; Ferretti G; Venuta F; Berloco PB; Coloni GF; Pietropaoli P
Transplant Proc; 2007; 39(6):2005-7. PubMed ID: 17692677
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
Strasfeld L; Weinstock DM
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
[TBL] [Abstract][Full Text] [Related]
19. EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients.
Zaragoza R; Aguado JM; Ferrer R; Rodríguez AH; Maseda E; Llinares P; Grau S; Muñoz P; Fortún J; Bouzada M; Pozo JC; León R;
Rev Iberoam Micol; 2016; 33(4):187-195. PubMed ID: 27067875
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
Solé A
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
